On Wednesday, Shares of TherapeuticsMD, Inc. (NYSEMKT:TXMD), dropped -2.92% to $6.64.
TherapeuticsMD, declared that it will hold a conference call and live audio webcast to talk about first quarter 2015 financial and business results on Tuesday, May 5. The conference call and webcast will take place at 4:30 p.m. EDT. TherapeuticsMD CEO Robert G. Finizio and Chief Financial Officer Dan Cartwright will host the call.
TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, counting prenatal vitamins, iron supplements, vitamin D supplements, and natural menopause relief products under the vitaMedMD brand, in addition to duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name.
Shares of Omega Healthcare Investors Inc. (NYSE:OHI), declined -2.91% to $36.65, during its last trading session.
Omega Healthcare Investors, declared its results of operations for the three-month period ended March 31, 2015. The Company also stated for the three-month period ended March 31, 2015 Funds From Operations accessible to common stockholders of $79.6 million or $0.59 per common share and Funds Accessible For Distribution to common stockholders of $87.5 million or $0.65 per common share.
In Q2 2015, the Company
- accomplished the acquisition by merger of Aviv REIT, Inc. (“Aviv”).
- raised its quarterly common stock dividend rate to $0.54 per share.
In Q1 2015, the Company…
- issued $700 million aggregate principal amount of its 4.5% Senior Notes due 2027.
- accomplished an underwritten public offering of 10.925 million shares of its common stock.
- redeemed $200 million aggregate principal amount of its 7.5% Senior Notes due 2020.
- paid off $147 million of secured long-term debt.
- accomplished $6 million in new investments.
- invested $9 million in capital renovation projects.
- raised its quarterly common stock dividend to $0.53 per share.
Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. was founded in 1992 and is based in Maryland, United States.
At the end of Wednesday’s trade, Shares of B&G Foods Inc. (NYSE:BGS), dwindled -2.89% to $30.92.
B&G Foods, declared that it has priced its offering of 4,200,000 shares of its common stock at a price to the public of $30.60 per share. The offering is predictable to close on May 4, 2015.
After deducting underwriting discounts and commissions and other estimated offering expenses, B&G Foods anticipates to use the net proceeds of the offering for general corporate purposes, which may comprise, among other things, the repayment or retirement of a portion of B&G Foods’ long-term debt or future acquisitions, if any.
Barclays Capital Inc. is acting as the underwriter for the offering.
B&G Foods, Inc. manufactures, sells, and distributes shelf-stable food and household products in the United States, Canada, and Puerto Rico. Its portfolio of products comprise hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, wine vinegar, maple syrup, molasses, salad dressings, Mexican-style sauces, dry soups, taco shells and kits, salsas, pickles, peppers, tomato-based products, puffed corn and rice snacks, nut clusters, Greek yogurt coated granola bars and bites, and other specialty products.
Finally,
ended its last trade with -2.87% loss, and closed at $27.77.
Today, CommScope, stated sales of $825 million and net income of $39 million, or $0.20 per diluted share for the quarter ended March 31, 2015. Non-GAAP adjusted net income for the first quarter of 2015 was $81 million, or $0.42 per diluted share.
For the quarter ended March 31, 2014, CommScope stated sales of $935 million and net income of $64 million or $0.34 per diluted share. Non-GAAP adjusted net income for the first quarter of 2014 was $95 million, or $0.50 per diluted share.
On January 28, 2015, CommScope declared a contract to acquire TE Connectivity’s Telecom, Enterprise and Wireless businesses. This business is a global leader in fiber optic connectivity for wireline and wireless networks, and the transaction is predictable to be in excess of 20 percent accretive to CommScope’s adjusted earnings per share by the end of the first full year after closing, not taking into account purchase accounting charges, integration costs and other special items.
First Quarter 2015 Overview
First quarter 2015 sales declined 12 percent year over year to $825 million. Growth in the Enterprise and Broadband segments was offset by lower North American Wireless sales. Foreign exchange rate changes negatively affected sales by 3 percent in the quarter contrast to the preceding year period.
Operating income in the first quarter declined 36 percent to $93 million, contrast to $147 million in the same period last year. Adjusted operating income, which excludes amortization of purchased intangibles, restructuring costs and other special items, declined 18 percent year over year to $156 million.
GAAP net income reduced 39 percent year over year to $39 million. Not taking into account amortization of purchased intangibles, restructuring costs and other special items, first quarter adjusted net income reduced 14 percent year over year to $81 million. Adjusted earnings were $0.42 per diluted share, down 16 percent year over year.
CommScope Holding Company, Inc., together with its auxiliaries, provides connectivity and infrastructure solutions for wireless, business enterprise, and residential broadband networks worldwide. The company operates through three segments: Wireless, Enterprise, and Broadband.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
